Agents for diagnosing and treating melanomas, aromatic halogenat

Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

564161, A61K 3100, A61K 4300

Patent

active

051907410

ABSTRACT:
##STR1## The invention concerns agents for diagnosing and treating malignant melanomas, of general formula (I), in which X denotes a hydrogen or halogen atom, Y denotes a Z--CONH--, Z--O--, Z--S(O)--.sub.n1 group, n.sub.1 being equal to 0,1,2 or 3, a Z--SO.sub.2 --NH-- Z--NHCO-- group, Z being a bond, a --CH.sub.2 -- or --CH(C.sub.6 H.sub.5)-- group, n is an integer between 2 and 4, and R.sub.1 and R.sub.2 each denote a hydrogen atom, a C.sub.1 to C.sub.6 alkyl group or a C.sub.6 to C.sub.12 aryl or aralkyl group, these compounds possibly being labelled by radioisotopes chosen from .sup.123 I, .sup.123 I, .sup.123 I, .sup.75 Br, .sup.77 Br, .sup.18 F, or .sup.11 C or by stable isotopes chosen from .sup.13 C and .sup.19 F, as well as their addition salts with pharmaceutically acceptable acids. The invention also concerns the use of these compounds to manufacture an agent for diagnosing and/or treating malignant melanomas.

REFERENCES:
patent: 4279887 (1981-07-01), Baldwin et al.
"Synthese etude chez le rat, de composes radioiodes utilisables pour l'exration du systeme nerveux central", Eur. J. Med. Chem. Chim. Ther., vol. 21, No. 5, 1986, by M.-F. Moreau et al., pp. 423-431.
"Interactions of the novel inhibitors of MAO-B Ro 19-6327 and Ro 16-6491 with the active site of the nezyme", Pharmacological Research Communications, vol. 20, suppl. IV, 1988, by A. M. Cesura et al, pp. 51-61.
"Ro 16-6491: A new reversible and highly selective MAO-B inhibitor protects mice from the dopaminergic neurotoxicity of MPTP", Advances in Neurology, vol. 45, 1987, by M. Da Prada et al., pp. 175-178.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Agents for diagnosing and treating melanomas, aromatic halogenat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Agents for diagnosing and treating melanomas, aromatic halogenat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Agents for diagnosing and treating melanomas, aromatic halogenat will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-125346

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.